PER
Click for more information
0.00% 8.0¢ percheron therapeutics limited

various models on licensing negotiation , page-4

  1. introvert
    88 Posts.
    clock Created with Sketch.
    05/07/12
    14:57
    Post #: 10398334
    Afandin option for ATL1101 has expired.

    TJAB deal if goes through will fund the developments of ATL1102 and to my understanding no upfront payment will be made.

    We are not sitting in US. Australian market has performed very poorly and I personally am not raising my hopes.
    ANP Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
MBK Metal Bank setting up shop in Saudi Arabia as part of MENA expansion plans
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 8.0¢ $76.78K 958.6K

Buyers (Bids)

No. Vol. Price($)
2 225430 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 45694 2
View Market Depth
Last trade - 12.48pm 20/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.